ATM inhibition enhances the effectiveness of immune checkpoint blockade treatment in breast cancer by facilitating the cytoplasmic leakage of mtDNA and the activation of the cGAS-STING pathway (Hu M. et al., 2021). Here, STING1 is linked to breast cancer.